No Data
No Data
Special treat Jiuzhi (000989.SZ): accumulated repurchase of 1.10% of shares.
ST Jiuzhi (000989.SZ) announced that as of June 30, 2024, the company has repurchased a total of 9,410,000 shares through a repurchase special securities account in a centralized bidding trading manner, accounting for 1.10% of the total current share capital. The highest fill price was 8.21 yuan/share, the lowest fill price was 7.67 yuan/share, and the total trade amount was RMB 74,324,700 (excluding transaction fees).
Are Jiuzhitang Co., Ltd.'s (SZSE:000989) Mixed Financials Driving The Negative Sentiment?
Jiuzhitang (SZSE:000989) has had a rough three months with its share price down 27%. It seems that the market might have completely ignored the positive aspects of the company's fundamentals and dec
ST Jiuzhi (000989.SZ): Controlling shareholder Li Zhenguo lifted the pledge of 12.96 million shares
Gelonghui, May 30 | ST Jiuzhi (000989.SZ) announced that the company recently received a letter from the controlling shareholder, Mr. Li Zhenguo, to learn that some of the company's shares were released from the pledge. The number of shares released this time is 12.96 million shares. The total number of shares pledged by the controlling shareholders of the company accounts for more than 80% of the company's shares. Investors are requested to pay attention to related risks. According to the company's controlling shareholder's explanation, currently its cumulative share pledge is mainly used for personal guarantee business. The purpose of the guarantee is to obtain funds for stock pledge financing. The increase in the share pledge ratio is a phased increase in the financing replacement process
ST Jiuzhi (000989.SZ): In 2023, the company's OTC products achieved total revenue of 1.05 billion yuan
Gelonghui, May 27丨ST Jiuzhi (000989.SZ) said on the investor interactive platform that in 2023, the company's sales revenue for seven varieties, including Shuxuetong Injection, Liuwei Dihuang Pills, Angong Niuhuang Pills, Donkey Gum Blood Supplementation Granules, Zu Guang San, Ejiao, and Xiaoyao Pills, exceeded 100 million. The operating income of the individual products of Chuxetong Injection, Siqikang, and Nuhua Purple Pearl tablets can be compared to the operating income of the company's wholly-owned subsidiaries Youbo Pharmaceutical, Sky Biotech, and Hainan Jiuzhitang, which were 602 million yuan, 66 million yuan, and 47 million yuan respectively. In 2023, the company's OTC products achieved a total revenue of 15.05
ST Jiuzhi (000989.SZ): The controlling shareholder lifted the pledge of 76.933,900 shares of the company
Gelonghui, May 23 | ST Jiuzhi (000989.SZ) announced that the company recently received a letter from the controlling shareholder, Mr. Li Zhenguo, to learn that some of the company's shares were released from the pledge. The number of shares released this time is 76.933,900 shares.
Jiuzhitang Co., Ltd.'s (SZSE:000989) Business And Shares Still Trailing The Market
When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 33x, you may consider Jiuzhitang Co., Ltd. (SZSE:000989) as an attractive investment with its 22x P/E ratio.
No Data